Article
A conserved immunometabolic transcriptional programme defines MASLD progression and is maintained in hepatocellular carcinoma
2026-04-07
Abstract excerpt
<title>Abstract</title> <p>Metabolic dysfunction–associated steatotic liver disease (MASLD) constitutes a primary cause of hepatocellular carcinoma (HCC). However, the transcriptional programs linking disease progression to tumor biology remain incompletely defined. Here, we aimed to identify conserved transcriptional programs underlying MASLD progression and to determine their biological organization, cellular c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7dfefcc1-08e5-56ff-b944-6e6a195d253f
- DOI
- 10.21203/rs.3.rs-9310352/v1
